| Document |
Document Title |
|
WO/2024/071980A1 |
The present invention pertains to: a xanthene derivative compound having a high refractive index; and a method for producing same. More specifically, the present invention pertains to: a high refractive index monomer that has a xanthene-...
|
|
WO/2024/048438A1 |
The present invention addresses the problem of providing: a diastereomer preparation method whereby it becomes possible to produce a desired diastereomer from a diastereomer mixture with high efficiency; and a solid-phase photosensitizer...
|
|
WO/2023/230702A1 |
Screening for novel antibacterial compounds in small molecule libraries has a low success rate. Here, we applied a machine learning (ML)-based virtual screening for antibacterial activity and evaluated its predictive power by experimenta...
|
|
WO/2023/223855A1 |
The present invention provides: a compound which is represented by formula (1) (each of the symbols in formula (1) is as defined in the description); an organic electroluminescent element which contains this compound; and an electronic d...
|
|
WO/2023/216432A1 |
The present application relates to a thioxanthone derivative, a method for preparing same, and use thereof. The thioxanthone derivative has a structure represented by formula (1). The thioxanthone derivative provided by the present appli...
|
|
WO/2023/218203A1 |
The present invention relates to compounds that are MALT1 inhibitors. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical c...
|
|
WO/2023/208837A1 |
The present invention relates to oligomeric binaphtyl compounds of the formula (I) that are suitable as monomers for preparing thermoplastic resins, such as polycarbonate resins, which have beneficial optical and mechanical properties an...
|
|
WO/2023/190161A1 |
The present invention provides a polymerization initiator (A) which contains a dialkyl peroxide (a-1) that has a thioxanthone skeleton represented by general formula (1) and a hydroperoxide (a-2) that has a thioxanthone skeleton represen...
|
|
WO/2023/151662A1 |
Provided are an androgen receptor activity regulator and the use thereof. The androgen receptor activity regulator has a structure as represented by formula 1-I or formula 2-I, wherein R1-R7, X, ring A, ring B, ring C, n, m, p, Z1 and Z2...
|
|
WO/2023/153169A1 |
The present disclosure provides an organic compound represented by general formula (1). (In general formula (1), R1 to R20 are each independently selected from the group consisting of a hydrogen atom, a deuterium atom, a halogen atom, an...
|
|
WO/2023/151394A1 |
The present invention relates to the technical field of organic electroluminescent materials, and in particular, to a fluorene derivative and a use thereof. The structural formula of the fluorene derivative is shown in formula (I). The f...
|
|
WO/2023/126223A1 |
The present invention relates to novel photoinitiators having hydroxyl groups and/or (meth)acrylate groups. The invention also relates to compositions comprising these photoinitiators as well as their use for photopolymerizing ethylenica...
|
|
WO/2023/023594A9 |
2‑diarylmethyl‑4‑aminotetrahydropyran derivatives are disclosed. The compounds include the following genus: or a pharmaceutically acceptable salt thereof. The compounds activate cellular PP2A, suppress oncogenic kinase signaling an...
|
|
WO/2023/078824A1 |
The present invention relates to compounds of the spiro-(indane- fluorene) type of formula (I), in particular those bearing a primary amino group and the corresponding diarylamino compounds. The invention further relates to methods for p...
|
|
WO/2023/051657A1 |
Provided are a compound as represented by formula I, and a racemate, an enantiomer, a diastereomer and a pharmaceutically acceptable salt thereof, and the use thereof in the prevention or treatment of related diseases caused by coronavir...
|
|
WO/2023/026884A1 |
To provide a curable composition that generates little outgas from an obtained cured product. The curable composition includes a radical polymerization initiator represented by formula 1 and a radical polymerizable compound. In formula 1...
|
|
WO/2023/011416A1 |
The present invention provides a compound targeting HDAC and NAD synthesis and a pharmaceutically acceptable salt, hydrate, deuterated substance, isomer, or prodrug of the compound, and preparation and application thereof. Specifically, ...
|
|
WO/2023/277605A1 |
The present invention provides a novel compound for a capping layer and an organic light-emitting device containing same.
|
|
WO/2023/277593A1 |
The present invention provides a novel compound for a capping layer, and an organic light-emitting device comprising same.
|
|
WO/2022/235264A1 |
Applicants have developed novel methods and compositions for controlling, treating, preventing, or ameliorating arthropod infection and identifying kinin receptor agonists and antagonists. Novel compositions include one or more active ag...
|
|
WO/2022/191312A1 |
[Abstract] [Problem] To provide a method for producing a dealkoxyphenylation product with high yield from a substrate, e.g., a sugar, which is bonded to an alkoxyphenyl group through an oxygen atom. [Solution] A substrate that is bonded ...
|
|
WO/2022/184292A1 |
The present invention relates to novel Norrish Type II photoinitiators which may be liquid or easily solubilized at room temperature. The invention also relates to compositions comprising these photoinitiators as well as their use for ph...
|
|
WO/2022/174525A1 |
The present invention relates to the fields of medicinal chemistry and pharmacotherapeutics, and in particular to a compound, a preparation method therefor and a use thereof, relating to the technical field of pharmacy. Provided are a co...
|
|
WO/2022/172685A1 |
Provided are a method for forming a resist pattern having excellent performance including sensitivity during a light exposure process, LWR performance and CDU performance even when a next-generation light exposure technology is applied t...
|
|
WO/2022/162471A1 |
Disclosed are compounds, compositions, and methods useful for treating neuronal and mitochondrial diseases.
|
|
WO/2022/157274A1 |
The invention relates to a polymerizable photoinitiator, to a process for preparing a polymerizable photoinitiator, to a polymerizable composition comprising a polymerizable photoinitiator and an ethylenically unsaturated compound. The i...
|
|
WO/2022/105845A1 |
A glucoside derivative, and a preparation method therefor and an application thereof. Specifically, provided is a glucoside derivative, which is a compound as represented by formula (I) or a pharmaceutically acceptable salt thereof. The ...
|
|
WO/2022/091691A1 |
A compound having at least one group represented by general formula (11) and including only one benz[de]anthracene derivative skeleton represented by general formula (1000) in the molecule. Ar1 is a substituted or unsubstituted aryl grou...
|
|
WO/2022/071116A1 |
A purpose of the present invention is to provide a thioxanthone compound having excellent reactivity to long-wavelength light. The present invention relates to a photopolymerization initiator comprising the thioxanthone compound, a curab...
|
|
WO/2022/060020A1 |
The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device using same and, more specifically, to: a compound having excellent thermal stability, electrochemical stability, light-...
|
|
WO/2022/054554A1 |
Provided is a highly active actinic-ray-sensitive acid generator which, upon irradiation with actinic rays, comes to have cationic-polymerization performance or crosslinking reaction performance and which enables curable compositions con...
|
|
WO/2022/053845A1 |
With the present invention, a compound [OH-TX-S-]2, gold nanoparticles (AuNps) coated with a coating layer containing same, AuNPs synthesized with a PdI of 0.45±0.01 and a core diameter of 30±1 nm, and the versions thereof coated with ...
|
|
WO/2022/025117A1 |
The present invention provides the compound represented in general formula (A1) [Ar1 is a C6-14 aryl group or a C5-14 nitrogen-containing heteroaryl group, substituted with at least two electron-attracting groups; R1 is a C1-30 alkyl gro...
|
|
WO/2022/022372A1 |
Disclosed in the present invention are a thiobenzopyran compound as shown in formula I and an application of a pharmaceutically acceptable salt of the thiobenzopyran compound in preparation of a drug for treating rheumatoid arthritis, wh...
|
|
WO/2022/018968A1 |
The present invention provides a useful photoacid generator which is contained in a photocurable composition, a chemically amplified positive photoresist composition and a chemically amplified negative photoresist composition, and which ...
|
|
WO/2021/249566A1 |
Provided are a benzo six-membered ring derivative for treating liver fibrosis and use thereof. Specifically, provided are a compound as shown in formula (I), a pharmaceutical composition containing the compound of formula (I), and use of...
|
|
WO/2021/246363A1 |
A purpose of the present invention is to provide a sealing agent for liquid crystal display elements, which has excellent curability at light shielded parts and which is capable of preventing gelling and thickening when dissolving a phot...
|
|
WO/2021/226276A2 |
Provided are compounds of Formula (II): or a pharmaceutically acceptable salt thereof, wherein R1, n, and Y1 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (II), or a ph...
|
|
WO/2021/204175A1 |
Provided herein are lipids that can be used in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid...
|
|
WO/2021/200179A1 |
The present invention provides an actinic-ray-sensitive or radiation-sensitive resin composition comprising (A) a resin which increases in polarity by the action of an acid and (B) a compound which generates an acid upon irradiation with...
|
|
WO/2021/170913A1 |
Chemical modulators of PP2A, comprising tricyclic sulfonimidamides are disclosed. The compounds are useful in preventing or treating cancer, diabetes, autoimmune disease, solid organ transplant rejection, graft vs host disease, chronic o...
|
|
WO/2021/159015A1 |
Provided are compounds of Formula (II) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and p are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formul...
|
|
WO/2021/149998A1 |
The present invention provides a novel compound, an organic electric element using same, and an electronic device having same, the novel compound capable of improving the light-emitting efficiency, stability and lifespan of the element.
|
|
WO/2021/144582A1 |
Latent photoinitiator compounds are described, as well as compositions containing such compounds and their uses in photoinitated methods for producing photoresist structured.
|
|
WO/2021/125834A1 |
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability and lifespan of an element; an organic electrical element using same; and an electronic device thereof.
|
|
WO/2021/104506A1 |
A cyclic sulfone compound and a preparation method therefor, a pharmaceutical composition thereof and use thereof. Specifically, the cyclic sulfone compound and a pharmaceutically acceptable salt are represented by formula (I), and can b...
|
|
WO/2021/103060A1 |
Disclosed are a hole transport material, a preparation method therefor, and an organic light emitting device, the hole transport material comprising a compound having a chemical structure represented by formula I, Z comprising a carbon a...
|
|
WO/2021/103728A1 |
An organic compound and an organic electroluminescent device using the compound used for the field of organic electroluminescence. The organic compound is as shown in structural formula I, wherein Ar1 to Ar 4 are independently selected f...
|
|
WO/2021/085372A1 |
An embodiment of the present invention pertains to a resin composition, a compound (Z), an optical filter, or a solid-state imaging device and optical sensor device using the optical filter. The resin composition contains a resin, and a ...
|
|
WO/2021/064189A2 |
The present invention relates to novel compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds provided herein can act as prostaglandin E2 (PGE2) EP4 receptor antagonists, which renders them hig...
|
